Skip to main content

The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.

Featured Articles

Biomarkers

The Limitations of Genomics-Only Liquid Biopsy: Functional Insights from Circulating Tumor Cells in Precision Oncology

It is well-known that cancer management presents numerous challenges, challenges that crop up from the beginning of care—at diagnosis.
Continue Reading
Managing Your Wealth

Baby on the Way? Here’s How You Can Prepare Financially

If you are expecting a baby, or have recently adopted one into your family, you have likely begun making big plans for the future.
Continue Reading
Health Disparities

Newly Launched HOPA Pharmacy Peer Network Covers Bispecific Antibody Therapies

The Hematology/Oncology Pharmacy Association (HOPA) has launched a collaborative network designed to help hematology/oncology pharmacists and other clinicians to more efficiently navigate complex practice challenges.
Continue Reading

Top Trending Articles

US-Based Clinical Trials That Are Actively Recruiting in Cervical Cancer
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Encourage Your Patients to Participate! US-Based Clinical Trials That Are Actively Recruiting in Testicular Cancer

In the Literature

Consumption of Ultra-Processed Foods Linked to Higher Cancer Risk
RIT Researcher Develops Math Models to Help Predict Patients’ Medication Adherence
Provider and Patient Education Critical for Improving Biosimilar Adoption

Healthcare Disparities

Implementing an Oral Cancer Drug Repository Service: Cowell Family Cancer Center
Study Shows Health Insurance Status Mediates Racial and Ethnic Inequities in Advanced-Stage Cervical Cancer
Addressing Health Equity in Bladder Cancer Care

Practical Issues for Pharmacists

The Limitations of Genomics-Only Liquid Biopsy: Functional Insights from Circulating Tumor Cells in Precision Oncology
Newly Launched HOPA Pharmacy Peer Network Covers Bispecific Antibody Therapies
Finding the Balance: Is Work-Life Harmony Attainable as an Oncology Pharmacist?

Featured Video

Longer-Term Follow-Up of Amivantamab + Lazertinib vs Osimertinib From the MARIPOSA Study

In the final video of this Rapid Reactions series, Beth Sandy, MSN, CRNP, FAPO, discusses data that continue to favor first-line amivantamab plus lazertinib over osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer after a median of 31 months of follow-up.

View Video
View Video Series

OCTOBER SPOTLIGHT

October Is Breast Cancer Awareness Month

October is Breast Cancer Awareness Month. The purpose of this national campaign–– which encompasses a wide range of initiatives conducted by local community organizations, breast cancer advocacy organizations, and major retailers–– is to educate the public about breast cancer risk factors, promote screening and prevention, support individuals diagnosed with the disease and their loved ones, and raise funds for breast cancer research. Breast Cancer Awareness Month has been on the national calendar since 1985.

View Breast Cancer Articles

FDA Updates

FDA Granted Second Approval for Epkinly to Treat Patients With Relapsed or Refractory Follicular Lymphoma
FDA News: September 11, 2023, to October 16, 2023
FDA News: August 9, 2023, to August 14, 2023

Value-Based Care
 

Biosimilars in Oncology Can Reduce Healthcare Costs
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Study Confirms Cost Savings Associated with Telehealth Use in Cancer Care